Healthcare Sales & Marketing Network News: intranasal amphotericin B

Searching News Database: intranasal amphotericin B

HSMN NewsFeed - 15 Aug 2007
Accentia Biopharmaceuticals Updates Interim Analysis of Blinded Clinical Results in the Fast-Tracked Pivotal Phase 3 Trial of SinuNase for the Treatment of Refractory Chronic Sinusitis
Biopharmaceuticals

HSMN NewsFeed - 14 May 2007
Accentia Biopharmaceuticals Makes Milestone Payment Based on Fast Tracked Pivotal Phase 3 Study with SinuNase for the Treatment of Chronic Sinusitis
Biopharmaceuticals

HSMN NewsFeed - 21 Dec 2006
Accentia Biopharmaceuticals in Discussions with Pharmaceutical Companies on SinuNase Partnership
Biopharmaceuticals

HSMN NewsFeed - 20 Apr 2006
National Survey of U.S. Otolaryngologists First to Measure Dissatisfaction with Current Treatments for Chronic Sinusitis
Biopharmaceuticals

HSMN NewsFeed - 12 Apr 2006
FDA Grants Accentia Biopharmaceuticals Fast Track Status for SinuNase(TM)
Biopharmaceuticals FDA

HSMN NewsFeed - 14 Feb 2006
SinuNase(TM) IND On Track
Biopharmaceuticals

Return to NewsFeed

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.

FindReps - available on the Apple App Store for iPhone and iPad.